Xact Kapitalforvaltning’s Ligand Pharmaceuticals LGND Stock Holding History

Xact Kapitalforvaltning’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	$281K	Hold	6,184	–	–	0.01%	1051
2019 Q4	$402K	Buy	6,184 +2,564	+71%	+$171K	0.01%	1101
2019 Q3	$225K	Buy	+3,620	New	+$227K	﹤0.01%	1343
2019 Q2	–	Sell	-6,505	Closed	-$510K	–	1460
2019 Q1	$510K	Hold	6,505	–	–	0.01%	907
2018 Q4	$551K	Hold	6,505	–	–	0.01%	816
2018 Q3	$1.11M	Hold	6,505	–	–	0.02%	560
2018 Q2	$841K	Buy	6,505 +962	+17%	+$107K	0.02%	648
2018 Q1	$571K	Buy	5,543 +1,443	+35%	+$143K	0.01%	758
2017 Q4	$350K	Buy	+4,100	New	+$355K	0.01%	839

Other funds holding LGND

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCMLC

Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

SDJVC

St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return

Xact Kapitalforvaltning's LGND Position: Q1 2020 in Review

Xact Kapitalforvaltning held its Ligand Pharmaceuticals (LGND) position steady in Q1 2020 at 6,184 shares worth $281K. The position accounts for 0.01% of the portfolio, ranked #1051.

Xact Kapitalforvaltning first reported a position in LGND in Q4 2017 and has held it in 9 quarters since. The position peaked at $1.11M in Q3 2018. 262 funds tracked by Wall St. Rank hold LGND as of Q1 2020.

Xact Kapitalforvaltning held 6,184 shares of Ligand Pharmaceuticals worth $281K as of Q1 2020.
Xact Kapitalforvaltning left its Ligand Pharmaceuticals share count unchanged in Q1 2020.
Ligand Pharmaceuticals made up 0.01% of Xact Kapitalforvaltning's portfolio in Q1 2020, its #1051 holding.
Xact Kapitalforvaltning first reported a position in Ligand Pharmaceuticals in Q4 2017 and has held it in 9 quarters since.
Xact Kapitalforvaltning's Ligand Pharmaceuticals position peaked at $1.11M in Q3 2018.
262 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2020.

Based on Xact Kapitalforvaltning's 13F filing for Q1 2020, filed 14 May 2020.